Hofseth BioCare
Be the first to follow this company
Hofseth BioCare´s key objective is to provide bio marine ingredients for human applications. Through innovative production technology and logistics, we preserve the quality of protein, calcium and oil extracted from fish.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Oslo Børs
HBC
Daily low / high price
-
Market cap
-
Turnover
-
Volume
-
Financial calendar
Interim report
2024-08-23
Interim report
2024-11-08
Annual report
2025-02-14
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
SIX SIX AG | 20.7 % | 20.7 % |
RH Industri AS | 17.5 % | 17.5 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.
Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools